Kyoto, Japan

Tohru Komano

This inventor holds 2 USPTO granted patents. Top assignees: Kirin Beer Kabushiki Kaisha, Marubeni Kabushiki Kaisha, Suntory Limited. Active years: 1987-1995.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1987-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tohru Komano: Innovator in Genetic Engineering

Introduction

Tohru Komano is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of genetic engineering, particularly in the expression of multidrug resistance-related genes in yeast cells. With a total of 2 patents, his work has implications for both biotechnology and medicine.

Latest Patents

Komano's latest patents include innovative methods for expressing MDR-related genes in yeast cells. One patent describes a yeast host capable of expressing P-glycoprotein, which is crucial for understanding multidrug resistance. This invention involves connecting the MDR-related gene to a yeast expression vector and transforming the yeast with the recombinant vector. Another patent focuses on a promoter derived from chloroplast DNA, which integrates with DNA from procaryotes into a vector, enhancing the understanding of gene expression mechanisms.

Career Highlights

Throughout his career, Tohru Komano has worked with prominent companies such as Suntory Limited and Kirin Beer. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in biotechnology.

Collaborations

Komano has collaborated with notable colleagues, including Yuji Shibano and Kazumitsu Ueda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in genetic research.

Conclusion

Tohru Komano's contributions to genetic engineering and his innovative patents highlight his role as a significant inventor in the field. His work continues to influence advancements in biotechnology and medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…